Continuing concerns over imported pharmaceuticals: hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001, Volume 4
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
50 dosage units addictive agencies Americans APIs border bulk Burr ceutical Chairman coming committee companies concerns consumers controlled substances counterfeit drugs counterfeit pharmaceuticals counterfeit products criminal dangerous declared DeGette detained Deutsch diazepam Dingell diversion drug abuse Drug Enforcement Administration drug importation drug products enforcement entering the U.S. FDA approved FDA's Federal flunitrazepam Food and Drug foreign Greenwood hearing Hubbard illegal importation of controlled individuals inspectors international mail Internet pharmacies investigation issue labels Laredo legitimate mail facility manufactured medicines Mexican Mexico Nagel Novartis Nuevo Laredo Oxycodone Oxycontin packages parcels percent personal importation Peter Deutsch phar pharma pharmaceutical products pills potential Prepared Statement prescription drugs problem public health purchased question regulation regulatory require risk Rode safety Shepherd shipments Stupak Subcommittee tablets testimony Texas Tijuana tion Trundley U.S. citizens U.S. Customs Service U.S. residents unapproved